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Abstract: 
Background: The significant increase in the use of implantable cardiac devices (ICDs) has been accompanied 
by biofilm formation and increase rate of infection on the devices. The purpose of our study is to describe the 
clinical and microbiological findings of infection of ICDs in the cardiology units of western Algeria hospitals. 
Methodology: All patients with clinical diagnosis of ICD infections or infective endocarditis upon removal of 
their ICDs from December 2012 to August 2014 in cardiology units of 4 Algerian hospitals were included in the 
study. Each element of the ICD pocket and lead was separately sonicated in sterile saline, inoculated onto 
Chapman and MacConkey agar plates and incubated aerobically at 37oC for colony count after 24 hours. 
Biochemical identification of the bacteria isolates was made by API 20E, API 20 NE and API Staph, and 
confirmed by Siemens Healthcare Diagnostics WalkAway® 96 Plus System. Antibiotic susceptibility testing on 
each isolate was performed by the disk diffusion method on Mueller Hinton agar. Biofilm formation was 
detected by Congo Red Agar (CRA) and Tissue Culture Plate (TCP) methods, and hydrophobicity of the bacterial 
cell was determined by the MATH protocol.                             
Results: Over a period of twenty-one months, 17 ICDs were removed from patients with post-operative 
infections; 6 (35.3%) had early infection of ICD and 11 (64.7%) had late ICD infection. Fifty-four bacterial 
strains were isolated and identified, with coagulase-negative staphylococci being the predominant bacteria with 
46.3% (25/54). There was no significant association between hydrophobicity and antimicrobial resistance in the 
54 isolates but there is positive correlation between biofilm production and antimicrobial resistance, with the 
strongest biofilm producers resistant to more than one antibiotic. Four independent predictors of infection of 
resynchronization devices were reported; reoperation, multi-morbidity, long procedure, and ICD implantation. 
Conclusion: Our study is the first in Algeria to describe microbiological characteristics of ICD infection. The 
bacteria in the biofilm were protected, more resistant and tolerated high concentrations of antibiotics and thus 
played a major role in the development of ICD infections. Despite the improvements in ICD design and 
implantation techniques, ICD infection remains a serious challenge.  
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Résumé: 
Contexte: L'augmentation significative de l'utilisation des dispositifs cardiaques implantables est un risque 
majeur d'augmentation du taux d'infection et donc du risque de formation d'un biofilm sur ce genre de  
dispositifs. L'objectif de notre étude est de décrire les résultats cliniques et microbiologiques de l'infection sur 
les dispositifs cardiaques implantables (DCI) dans les unités de cardiologie des hôpitaux de l'ouest Algérien. 
Méthodologie: Tous les patients cliniquement diagnostiqués avec une infection sur DCI, ou une endocardite 
infectieuse et ayant subit un retrait de leur dispositif cardiaque sont inclus dans cette étude et cela sur une 
période entre décembre 2012 et aout 2014 dans 4 unités de cardiologie. Chaque élément du DCI (boitier et 
sonde) est trempé séparément dans une solution saline stérile, ensemencé sur deux milieux de culture, un 
milieu de Chapman et un milieu MacConkey et incubé en aérobiose à 37°C pour la numération des colonies 
après 24 heures. L'identification biochimique des isolats de bactéries est effectuée par le API 20E, API 20 NE et 
API Staph, et confirmée par le système WalkAway® 96 Plus de Siemens Healthcare Diagnostics. Les tests de 
sensibilité aux antibiotiques de chaque isolat sont effectués par la méthode de diffusion des disques sur gélose 
de Mueller Hinton. La formation d'un biofilm est détectée par les méthodes de la gélose rouge du Congo (CRA) 
et de la plaque de culture tissulaire (TCP), et l'hydrophobicité de la cellule bactérienne est déterminée par le 
protocole MATH.                             
Résultats: Sur une période de 21 mois, 17 DCI sont retirés de patients atteints d'infections postopératoires; 6 
patients (35,3%)  sont identifiés comme ayant une infection précoce sur leurs DCI et 11 patients (64,7%)  
ayant une infection tardive. Cinquante-quatre souches bactériennes sont isolées et identifiées, les 
staphylocoques à coagulase négative étant les bactéries prédominantes avec 46,3% (25/54). Il n'y a pas 
d'association significative entre l'hydrophobicité et la résistance aux antimicrobiens dans les 54 isolats, mais il 
existe une corrélation positive entre la production de biofilm et la résistance aux antimicrobiens, les plus 
puissants en biofilm sont résistant à plus d'un antibiotique. Quatre facteurs prédictifs indépendants d’infection 
des dispositifs cardiaques implantable sont retrouvés dans ce travail: ré-intervention, longue procédure, sujets 
multi-tarés, et implantation d’un DCI         
Conclusion: Notre étude est la première en Algérie à décrire les caractéristiques microbiologiques de l'infection 
des DCI. Les bactéries présentes dans le biofilm sont protégées, plus résistantes et tolèrent de fortes 
concentrations d'antibiotiques et jouent ainsi un rôle majeur dans le développement des infections par DCI. 
Malgré des améliorations dans les techniques de conception et d'implantation de DCI, l'infection des dispositifs 
cardiaques implantables reste un problème grave et très couteux. 
Mots-clés: dispositifs cardiaques implantables; staphylocoque; résistance; biofilm; hydrophobicité  
Introduction: 
 The permanent implantable cardiac 
device (ICD) is one of the most widely used 
cardiac rhythm control devices. Since their 
introduction in the early 1980s, ICD have 
become a life-saving therapeutic tool for 
patients with ventricular arrhythmia. Virtually 
all the countries surveyed showed significant 
rise in the use of ICD, the largest implanter 
being the USA with 434 new implants per 
million populations (1). Despite improve- 
ments in cardiac device design, application of 
timely infection control practices, and admin- 
istration of antibiotic prophylaxis at the time 
of device placement, infections continue to be 
observed. The infection rate is highly varia- 
ble, ranging from 0.5 to 12% (2,3). 
 Infection of implantable cardiac 
device (ICD) may be local, limited to the 
pulse generator pocket and/or the sub- 
cutaneous portion of the leads, or systemic, 
involving the transvenous intravascular elect- 
rode (4). Several factors have been reported 
to be associated with a greater risk of ICD 
infections and these include; immuno- 
suppression (e.g. renal dysfunction and corti- 
costeroid use); oral anticoagulation use; co- 
existing illnesses; periprocedural factors incl- 
uding failure to administer perioperative anti- 
microbial prophylaxis; device revision/repla- 
cement; and operators’ experience (5). 
 Because of the invasiveness, these 
devices have multiple comorbidities in ICD 
recipients, the benefits of which can be 
overshadowed by infectious complications. 
Infection of ICD is usually a serious and 
fearsome complication requiring both comp- 
lete removal of the infected device and 
systemic antimicrobial treatment (5,6). 
Although the implantation of pacemakers is a 
procedure characterized by low rate of 
complication, infections, mainly of the pace- 
maker generator pocket, is one of the most 
common complications with incidence ranging 
from 1 to 5%. Despite the low incidence, 
such infections have a worrying development, 
mostly because it is associated with high 
morbidity and potential fatality (7). 
 Microbiological diagnosis of ICD 
infection is of great importance for appro- 
priate treatment. Staphylococcal species incl-
uding Staphylococcus aureus and coagulase 
negative staphylococci (CoNS) represent the                                               




majority of bacterial agents of ICD infection 
(8,9). However, some unusual microorga- 
nisms such as Propionibacterium spp., 
Corynebacterium spp., Acinetobacter baum- 
annii, and Haemophilus influenzae may also 
be involved and antibiotic resistance is often 
detected in them (10,11). Furthermore, one 
major concern among professionals and 
bacteriologists is the risk of biofilm formation 
on the ICDs which consequently favors 
infection. In recent decades, biofilm forma- 
tions have been widely reported to be resp- 
onsible for nosocomial infections especially of 
prosthetic implants, tubes, leads and cathe- 
ters (12,13).     
 It is speculated that the presence of 
an ICD is conducive for microbial colonization 
contributing greatly to the development of 
biofilms, which in turn, explains the occur- 
rence of endocarditis (14,15). It is interesting 
to note that biofilm consists of a structured 
medium of microbial cells that adhere to a 
solid surface and is surrounded by a matrix of 
extracellular polymeric substances. This micr- 
obial combination is a form of protection enc- 
ouraging symbiotic relationships, tolerance, 
as well as antimicrobial resistance (16).
 The goal of this study is to first 
describe the bacteriological characteristics of 
ICD infections over a period of 2 years in four 
cardiology units of one private and three 
university hospital centers in western Algeria, 
and secondly to determine whether the 
isolated bacteria have the ability to form 
biofilms that may be responsible for 
triggering infection, especially in late stage 
endocarditis.  
Materials and method:   
Study setting:     
 This study is carried out at the 
Laboratory of Microbiology Applied to Food, 
Biomedical and Environment (LAMAABE) of 
the University Abou-Bekr Bekaid-Tlemcen, 
Algeria.  
Subjects     
 All the patients with clinical diagnosis 
of ICD infection or infective endocarditis upon 
removal of their cardiac devices from 
December 2012 to August 2014 in four 
cardiology units of three hospitals in Algeria 
were included in this study. The clinical 
diagnosis of ICD infection was made by the 
clinician based on local signs of inflammation 
such as erythema, heat, redness or purulent 
drainage, outward displacement of the 
pocket, septicemia or infectious endocarditis 
of the heart. The time of infection was 
recorded and ICD infection was categorized 
as; ‘very early’ if infection occurs 1 month 
after the latest ICD procedure; ‘early’ if 
infection occur between 2 and 12 months of 
the latest procedure, and ‘late’ if infection 
occurs 12 months after the latest procedure. 
Ethical approval                                              
 Ethical clearance was obtained from 
the Institutional Review Board at the Faculty 
of Health Science of the University of Algeria. 
The administrative authorizations were obta- 
ined from the Delegation of Public Health of 
the Regional Hospitals of Western Algeria. 
Moreover, written informed consent was 
obtained from all study patients prior to 
interview and DCI collection  
Collection of demographic and clinical data                                                                                                                                                                                                                                                                                                                                                        
 Demographic and clinical data 
collected from each patient by direct 
interview included age, gender, existence of 
an underlying anterior cardiopathy or a 
history of infective endocarditis, existence of 
diabetes, immunosuppression, primary impl- 
antation or change of pocket, antibiotic the- 
rapy and possible infection or surgery progra- 
mmed during the last five years.                        
Microbiological culture of the ICDs         
 After removal by the surgeons, the 
implantable cardiac devices (ICDs) were 
placed in sterile boxes and transported to the 
microbiology laboratory within 30 minutes. 
Each element of the ICD pocket and lead was 
soaked separately in sterile saline solution 
and sonicated for 5 minutes at a frequency of 
20Khz, and vortexed for 30sec to detach and 
detect sessile bacteria hanging on to these 
devices (17,18). After sonication, 100μL of 
the soaking liquid was inoculated onto 
Chapman agar and MacConkey agar plates. 
The number of CFU/mL was counted after 24 
hours aerobic incubation. The minimum 
detection threshold was 2 CFU/mL (19).                          
Biochemical identification and susceptibility 
testing of bacteria isolates                              
 The biochemical identification of the 
bacteria isolates was done using the API 20E 
and API 20NE Staph API (BioMérieux, Marcy 
l'Etoile, France), and confirmed by the 
Siemens Healthcare Diagnostics WalkAway® 
96 Plus System. The antibiotic susceptibility 
and resistance phenotypes were determined 
by the disk diffusion method on Mueller-
Hinton agar (Biorad, Marnes-la-Coquette, 
France) according to the recommendations of 
the antibiogram committee of the French 
Society of Microbiology (20). The antibiotic 
disks used were  penicillin (10iu), oxacillin 
(5µg), cefoxitin (30µg), gentamicin (10µg), 




tobramycin (10µg), amikacin (30µg), vanco- 
mycin (30µg), rifampin (30µg), fosfomycin 
(50µg), fusidic acid (10µg), clindamycin (2 
µg), pristinamycin (15µg), erythromycin (15 
µg), ofloxacin (5µg), tetracycline (30µg), chl- 
oramphenicol (30µg), imipenem (10µg), and 
trimethoprim/sulfamethoxazole (25µg), cefo- 
taxime (5µg), ceftriaxone (30µg), nalidixic 
acid (30µg), ciprofloxacin (5µg), amoxicillin 
(20µg), and clavulanic acid (10µg).                                       
Detection of biofilm by Tissue Culture Plate 
(TCP) method                                
 Quantitative measurement of biofilm 
production in the isolates was done using a 
microtiter assay. In brief, cells were grown 
overnight in Brain Heart Infusion Broth 
(BHIB).  The broth was then diluted 1:100 
and inoculated into microtiter plates. After 24 
hours incubation at 37°C, the plates were 
washed, stained with crystal violet, and the 
optical density measured at 570 nm (20). 
Each test was performed in triplicate. As a 
negative control, the uninoculated medium 
was used to determine the initial OD. Mean 
OD values were calculated for all tested 
strains and the negative control.   
 The threshold value (ODc) was estab- 
lished as three standard deviations (SD) 
above the mean OD of the negative control i. 
e. ODc=mean OD of the negative control + 
(3×SD of negative control). The ODc value 
was calculated separately for each microtiter 
plate. When a negative value was obtained, it 
was presented as zero, while any positive 
value indicated the production of biofilms. For 
the interpretation of the results, the classi- 
fication of the obtained results was based on 
the control OD. The strains are classified as 
follows: OD≤DOt (control) is non-biofilm 
forming; DOt×2≤OD≤DOt×4 is moderate 
biofilm-forming, and DOt×4≤OD is highly 
(strong) biofilm-forming (21).                                                                                                        
Detection of biofilm by Congo Red Agar (CRA) 
method                                 
 The Congo Red Agar method was 
used for detecting the ability of isolate to 
produce slime. The CRA medium was pre- 
pared with 37 g/L BHI broth, 50 g/L sucrose, 
10 g/L agar, and 0.8 g/L Congo Red. The 
Congo Red stain was prepared as a concen- 
trated aqueous solution and autoclaved at 
121°C for 15 min separately from other 
medium constituents, and was then added 
when the agar had cooled to 55°C. The plates 
were inoculated with bacterial isolate and 
incubated at 37°C for 24 hours. A positive 
result was indicated by black colonies while 
non-producing strains developed red colonies 
(22). For the evaluation of colonies colors, a 
four-color reference scale was used according 
to Satorres and Alcaráz (23). Black and 
almost black burgundy were classified as 
biofilm producers, while burgundy and red as 
non-biofilm producing strains. This test was 
performed in triplicate   
Hydrophobicity assays                   
 The hydrophobicity of the bacterial 
wall was evaluated with the MATH protocol 
(24) using hexadecane as a solvent. The 
bacteria strains were first grown in 50 mL of 
Luria Bertani (LB) and incubated for 18 hours 
at 37°C. The cells were recuperated by 
centrifugation at 5000 rpm for 15 min. The 
pellet obtained was then washed after two 
successive centrifugations with PBS (Phos- 
phate Buffered Saline pH 7.1) and suspended 
in the same buffer at an initial optical density 
(ODi) between 0.8 and 1 at 600nm. A volume 
of 0.3ml of each solvent was added to 1.8ml 
of bacterial suspension and the mixture was 
vortexed for 2 min. After a 20 min settling, 
the optical density (ODf) of the aqueous 
phase was measured at 600nm and the 
percentage of adhesion to solvent was then 
calculated using the following equation; CSH 
%=[(ODi-ODf)/ODi]×100 (25). A CSH of 0-
20% is defined as weak, 21-50% as mode- 
rate and > 40% as strong hydrophobicity.  
Results: 
 From December 2012 to August 
2014, a total of 315 implantable cardiac 
devices (ICDs) were implanted by the 
cardiology units of the four hospitals, out of 
which ICD was removed in 17 patients, all of 
whom developed infection on the ICDs, giving 
an infection rate of 5.4%. All 17 patients 
underwent only one surgical procedure 
except for one patient who had two surgical 
procedures within three months due to 
repeated infections of his ICD. The age range 
of the patients was 60 to 75 years; 13 
(76.4%) were male and 5 (29.4%) were 
diabetic.     
 All the patients were on antibiotic 
therapy on the day of cardiac device 
insertion. Four independent predictive factors 
of ICD infection identified were; reinter- 
vention, long procedure, multi-morbidity, and 
ICD implantation procedure. Six patients 
(35.3%) had early infection of ICD while 11 
patients (64.7%) had late infection. There 
were 9 patients with associated primary ICD 
implantation infections while there were 8 
with change of pocket ICD infection (Table 
1). 





 All 17 ICDs (pockets and leads) were 
positive for bacteria on culture plates, and 54 
bacteria (26 Gram positives and 26 Gram-
negatives) were isolated and identified, with 
the most frequent being coagulase-negative 
staphylococci (CoNS) representing 46.3% (25 
/54) of the total isolates (Table 2 and 3). A 
total of 27 bacterial isolates were recovered 
from the ICD pockets and 27 from the ICD 
leads. The most frequently isolated enteric 
bacteria were Pseudomonas spp, Klebsiella 
spp, Proteus spp., Serratia spp, and Entero- 




bacter spp identified in 9 ICDs comprising 29 
out of the 54 (53.7%) strains.   
 Other infrequently isolated bacteria 
from some ICDs included Ochrabactrum 
antropi, Ewingella americana, and Photo- 
bacterium damselae which were not asso- 
ciated with infectious endocarditis in the 
patients. Polymicrobial infection was recorded 
in 15 of the 17 patients (88.2%) with varying 
combinations of Pseudomonas aeruginosa, 
Staphylococcus sciuri, Vibrio fluviatis and  
Staphylococcus capitis while the infection was 
monomicrobial in a patient (P4) where the 
ICD pocket and the lead were colonized by 
the same Staphylococcus epidermidis strain 
and another patient (P2) where only the 
pocket was colonized by Staphylococcus 
xylosus (Table 1). 








 This study of antibiotic susceptibility 
of the isolated strains in the four hospital 
centers showed resistance at a significant 
level against several antibiotics (Fig 1 and Fig 
2). Fig 1 is a histogram illustrating the resis 
tant pattern of the Gram-negative bacterial 
isolates showing high resistance rate (>90%) 
                                                                 
                     
to amoxicillin, clavulanic acid, cefotaxime, 
and gentamycin, with 3 isolates resistant to 
imipenem. None of the staphylococcal strains 
was resistant to vancomycin. Fig 2 is a 
histogram illustrating the resistance pattern 
of the Gram-positive isolates. 
 
Fig 1: (Histogram A1): Resistance rate of Gram-negative bacteria isolates 
 
 













































                                        A                                                                  B 
Fig 3: Slime production in the strains isolated on Congo red medium                                                                                                 
A: slime generating, B: non-slime generating 
Results of biofilm detection  
 The results of the biofilm production 
by the bacterial isolates with the qualitative 
CRA and the quantitative TCP methods are 
presented in Table 2. Out of the 54 bacteria 
isolates, 44 (81.5%) were slime producers by 
the CRA method and 24 of them were strong 
(very good) biofilm producers using the TCP 
method, with OD 570 > 0.240. The TCP 
method detected biofilms in 48 (88.9%) of 54 
isolates with different intensities; 30 (55%) 
isolates were strong producers, 18 (33.3%) 
isolates were moderate, 6 (11.1%) isolates 
were low biofilm producers, while 10 (18.5%) 
were non-producers of biofilms. Thirty-seven 
(68.5%) of the 54 isolates were positive by 
both TCP and RCA methods. Fig 3 is a 
photograph of CRA plate showing slime prod- 
uction by a positive isolate (A) and non-slime 
production by a negative isolate (B).                                                          
Result of hydrophobicity                  
 The results of the microbial adhesion 
to the solvent (hydrophobicity) are summa- 
rized in Figs 4 and 5. A total of 14 Gram 
positive and 7 Gram negative bacteria 
isolates had affinity to hexadecane (apolar 
solvent) suggesting a weak hydrophilic 
character. On the other hand, 17 (41.5%) 
isolates were relatively hydrophobic between 
1% and 96%, and 2 (5%) strains were 
moderately hydrophobic. Fig 4 is a histogram 
of the cell surface hydrophobicity of the 
Gram-negative bacteria isolates and Fig 5 is a 
histogram of the cell surface hydrophobicity 
of Gram-positive bacteria isolates. 
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Fig 5: (Histogram B2): Cell surface hydrophobicity of Gram-positive bacteria isolates  
Discussion:  
 ICDs have become increasingly of 
great importance in the management of heart 
disease in many countries around the world 
with a great impact on the quality of life of 
patients (10). The advances in the 
development of permanent pacemakers and 
the technologies of implantable cardiac 
defibrillators have helped this process. 
Nevertheless, with the increase in ICD 
implantations, infections on these devices 
have correspondingly increased. To the best 
of our knowledge, this is the first and only 
study on the microbiological characteristics of 
ICD infections in Algeria. Although our data 
reflect the epidemiology of ICD infections in 
the region, they could be of great interest 
and provide useful information for ICD 
infections management in other regions.
 In recent decades, the rate of these 
ICD infections has increased worldwide from 
0.13% to 19.9% with an average rate of 10% 
(15,26). The overall incidence of infection on 
ICD implantable cardiac devices is estimated 
at 1.9 per thousand per year (27). According 
to an estimate by Camus et al., there are 
more than three million patients on 
pacemaker (PM) worldwide and 180,000 
carriers of implantable defibrillator (ID) (28). 
Among the complications occurring after the 
implantation of an ICD, infection is certainly 
the most serious (29). In this retrospective 
study of 21 months, of a total of 315 ICD 
implantations in 4 hospitals, 17 patients 
presented with infection of their ICDs, giving 
an incidence rate of 5.4%. All the infections 
were diagnosed and confirmed by specialist 
cardiologists  with  clinical  presentations that  
included erythema, heat, redness with or 
without purulent drainage, sepsis and infecti-
ous endocarditis. This rate is quite high when 
compared to other studies such as the French 
study by Klug and his team (30) in 2000 
where the incidence of infectious compli- 
cations was only 0.68%. In 2010, Baddour et 
al., (31) and Voigt et al., (32) estimated the 
incidence to be between 0.13% and 20%, 
which was related to the increase in the 
implantation rate of ICDs in the world in 
general. Of the 17 infected patients, 16 had 
infection of their pacemakers (PM), giving an 
incidence rate of 5.1% in the study. In the 
literature, the incidence of pacemaker 
infections is known to vary between 0.13% 
and 19.9% occurring mostly at the site of 
implantation of the generator, and in 10% of 
cases, it is the cause of infectious endo- 
carditis (33). Only one patient had an infec- 
tion after defibrillator implantation (DI) rep- 
resenting an incidence of 0.3%, which is 
known to vary between 0.7% and 1.2% (34).
 The infection of an ICD pocket is a 
rare but much feared early complication, 
which is defined as an infection occurring 
within the six months following the 
procedures (35) and often accompanied by 
fever and local signs that require urgent 
antibiotic therapy and immediate removal of 
the device (36). In our study, 6 of the 17 
(35.3%) infected patients had early infection 
of ICD. According to the study by Ben Abid et 
al., (37), 25% of ICD infections are early and 
42% are late, with no significant difference 
reported with respect to the type of infectious 
organisms. Nine of the 17 (52.9%) infected 
patients had an outward displacement of the 









































































compared to the study of Klug et al., (38) 
where 29.5% of the patients presented with 
an outward displacement of the pocket in a 
study of 105 patients.                 
 There are various factors predis- 
posing to ICD infection that have been 
reported including advanced age, diabetes, 
cancer and immunosuppression, anticoagu- 
lation, presence of a temporary stimulation 
lead, duration of intervention, and the 
surgeon’s experience (39). Indeed, diabetes 
mellitus and age are predisposing factors in 
most of our patients. The highest rate of 
infection was observed in the age group 60 to 
75 years who were mainly male patients 
among whom 29.4% were diabetic. A total of 
15 patients had positive cultures on the lead 
and the pocket of their ICDs, 8 of whom were 
infected by the same bacterium. Victor et al., 
(40) reported that the infection of the lead is 
associated with that of the pocket in every 
two cases. This infection can occur in 
isolation and in one fourth of cases a few 
weeks after implantation (40). The culture of 
the removed devices allows the possibility of 
an etiological diagnosis of ICD infection in the 
vast majority of cases. This means that 
microbiological analysis is mandatory in the 
case of suspicion of an ICD infection.                                                                                                                  
 A total of 54 bacteria were isolated 
and identified from the ICDs; 46.3% Gram 
positive bacteria were isolated, which were 
mostly CoNS with predominance of S. 
epidermidis. These findings closely agree with 
to those reported by Gill et al., (41) who 
estimated that about 41.2% of ICD infections 
were caused by CoNS. The dominant role of 
staphylococci is consistent with what has 
been previously reported where staphylo- 
coccal species accounted for 60 to 80% of the 
cases in most of the reported studies 
(36,42,44-44). In several studies, S. 
epidermidis was the most frequently isolated 
CoNS species and constitutes a significant 
part of the normal bacterial flora of human 
skin and mucous membranes from where it is 
easily introduced as a contaminant during 
surgical implantation of the polymer device 
(45).     
 Gram-negative bacteria constituted 
53.7% of the isolated bacteria, with high 
frequency of enteric bacteria such as Proteus 
spp, Serratia spp, Enterobacter spp and 
Pseudomonas spp. These bacteria which are 
involved contamination and care-related 
infections were recovered twice in the space 
of a few weeks in two different hospitals. This 
implies either contamination or poor tech- 
nique during the surgical procedure. We 
noted the exceptional recovery of three 
uncommon bacteria species; Ewingella ameri- 
cana, Ochrabactrum antropi, and Photo- 
bacterium damselae from the ICDs in our 
study, which have been reported only by a 
few authors such as Pien et al., (46), 
Mahmood et al., (47), and Austin et al., (48). 
Nevertheless, the important causative micro- 
organisms of ICD infections are CoNS 
followed by Gram-negative bacilli, fungi, non-
tuberculous mycobacteria and Bulkholderia 
cepacia. The bacterial complex is a rare cause 
of ICD infection with only a few cases of ICD 
pocket infection reported in the literature 
(41,49,50-51). ICD infections are mainly 
caused by the contamination of the local 
bacterial flora during implantation. Skin 
micro-organisms migrate from the insertion 
site along surface of the lead, colonize the 
intravascular distal portion, and finally infect 
the blood (52).    
 Nearly all of the isolated Gram-
negative bacteria in this study were resistant 
to ampicillin, amoxicillin, cefotaxime, and 
ceftriaxone. Although imipenem was highly 
active on the tested strains, three isolates 
were resistant to this antibiotic. These strains 
were also resistant to quinolones with rates 
ranging from 11.1% for ciprofloxacin to 
54.5% for nalidixic acid. Resistance rates of 
isolates to tetracycline and tobramycin were 
55.5% and 44.4% respectively. Unlike Gram-
negative bacteria, CoNS isolates displayed a 
higher level of sensitivity but with some were 
resistant to nalidixic acid and tetracycline. 
According to 2008 Camus study (28), 
majority of staphylococci are multi-sensitive 
with especial sensitivity to aminoglycosides, 
but the isolates in our study were resistant to 
kanamycin (28.5%) and tobramycin (18.5%).
 The development and persistence of 
bacterial infections are often associated with 
the foreign equipment and materials used in 
the devices and the ability of these bacteria 
to adhere to them. The bacterial strains 
implanted on the surface of a device are 
inserted and protected by a dense poly- 
saccharide extracellular matrix and are more 
resistant to antibiotics, constituting the 
biofilm that can be detected by quantitative 
and qualitative techniques (1). Adherence 
and persistence of CoNS infection are often 
associated with foreign materials. Adhesion is 
primarily related to non-specific physico- 
chemical forces, and then to specific 
interaction of the bacterial surface adhesins 
(not directly with the device) with host 
proteins coating the device (53). CoNS may 
adhere directly to the device plastic polymers 
via fimbria-like surface protein structures or 
via a capsular polysaccharidic adhesin (54). 
Bacteria may also adhere to host matrix 
proteins such as fibrinogen, fibronectin, and 




collagen that coat the surface of an implanted 
device (55). The layers of bacteria on the 
surface of an implanted device are encased in 
an extracellular slime made of a polysacc- 
haride intercellular adhesion and constitute 
the biofilm (56,57). Microbes in a biofilm are 
protected by this dense extracellular matrix 
and are more resistant to antibiotics and host 
defenses. Biofilm forming bacteria are there- 
fore a public health challenge for those 
requiring indwelling medical devices (56).
 In our study, the presence of 
infection was influenced by the ability of 48 
out of 54 strains to form a biofilm, whatever 
the support (pocket and leads), and thus 
representing a significant risk factor. The TCP 
technique, which is the most widely used 
method, is considered the ‘gold standard’ test 
for sensitive, accurate and reproducible 
screening method for the detection of biofilm 
production in clinical isolates (58). The 
adherence capacity of clinical isolates to host 
cells depends on bacterial surface properties 
such as hydrophobicity. In a recent study, it 
was reported that there is a significant 
difference in cell surface load between group 
B streptococci treated with antibiotics and 
those untreated (59). The determination of 
the acid-base properties (acceptor electron, 
donor electron) may be of great importance 
in many research areas of phagocytosis and 
microbial adhesion (60).  
 Our data indicated that affinity to 
hexadecane (apolar solvent) suggests low 
hydrophilicity for the majority of the bacteria 
isolated from surfaces of hydrophobic medical 
device. This contradicts several studies which 
reported that hydrophobic cells tend to 
adhere to hydrophobic substrates, while 
hydrophilic cells tend to adhere to hydrophilic 
substrates (61,62). It has also been sugge- 
sted that there is a positive correlation 
between the degree of bacterial hydro- 
phobicity and adhesion to abiotic surfaces 
(63). Our finding can be explained by the fact 
that these bacteria adhere to host proteins 
such as fibrinogen, fibronectin, and collagen 
which cover the surface of the implanted 
device, making it hydrophobic (55). The 
comparison between the biofilm formation 
(by RCA and TCP), hydrophobicity and 
antimicrobial resistance of the 54 bacteria 
isolates revealed that there is no significant 
association in terms of isolates but that there 
is correlation between biofilm formation and 
resistance to antibiotics, with the strong 




 This study is the first in Algeria to 
describe microbiological characteristics of ICD 
infections. CoNS were the most frequent 
cause of ICD infections in our study but 
Pseudomonas aeruginosa and Serratia spp 
were also significant cause of bacteremia in 
patients with ICD, with comparable rate to 
the CoNS. This situation may imply bacteria 
contamination or poor technique during 
surgical procedure for implantation of the 
ICDs.                
 The bacteria in the biofilm were 
protected, more resistant and tolerated high 
concentrations of antibiotics, and thus played 
a major role in the development of ICD 
infections. Despite the improvements in ICD 
design and implantation techniques, ICD 
infection remains a serious challenge. It is 
therefore essential that proper infection 
prevention and control practices be put in 
place as well as strict indications for antibiotic 
prophylaxis during implantation of ICDs. 
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